1‐Sulfonylated 1,2,3,4‐tetrahydroquinoline‐6‐carboxylic acids as simple, readily‐accessible MCL‐1 inhibitors-Reference-Cited by-同舟云学术

1‐Sulfonylated 1,2,3,4‐tetrahydroquinoline‐6‐carboxylic acids as simple, readily‐accessible MCL‐1 inhibitors

Published:2022-10-24 Issue:8 Volume:83 Page:1879-1889
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Development Research

Author:

Chen Lijia¹,Chan Alexandria M.¹,Wilder Paul T.²,Fletcher Steven¹³^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences University of Maryland School of Pharmacy Baltimore Maryland USA

2. Department of Biochemistry University of Maryland School of Medicine Baltimore Maryland USA

3. University of Maryland Greenebaum Cancer Center Baltimore Maryland USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Drug Discovery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ddr.22004

Reference29 articles.

1. A Novel Small-Molecule Inhibitor of Mcl-1 Blocks Pancreatic Cancer Growth In Vitro and In Vivo

2. 3-Substituted-N-(4-Hydroxynaphthalen-1-yl)arylsulfonamides as a Novel Class of Selective Mcl-1 Inhibitors: Structure-Based Design, Synthesis, SAR, and Biological Evaluation

3. Adams B.(2021 October 20).Amid Amgen's similar struggles AstraZeneca slams the brakes on MCL‐1 blood cancer drug. Fierce Biotech.https://www.fiercebiotech.com/biotech/amid-amgen-s-similar-struggles-astrazeneca-slams-brakes-mcl-1-blood-cancer-drug

4. The BCL-2 arbiters of apoptosis and their growing role as cancer targets

5. The landscape of somatic copy-number alteration across human cancers

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of N-sulfonylated aminosalicylic acids as dual MCL-1/BCL-xL inhibitors;RSC Medicinal Chemistry;2023